
DetectorToken Announces ICO for their Blockchain-based Bot
Aug 24, 2017 13:43 pm UTC| Business
If you are an avid user of cryptocurrencies who regularly trades various currencies through exchanges, you would understand the importance of staying up-to-date with the latest market trends and information about...
Lice Clinics of America Opens New Treatment Center in Oklahoma City
Aug 24, 2017 13:35 pm UTC| Business
Oklahoma City, Oklahoma, Aug. 24, 2017 -- Head lice infamously cause stress, disgust and embarrassment for millions of parents whose kids get infested each year. But thanks to the opening of a new Lice Clinics of...
Camposol Holding Ltd. Reports Second Quarter 2017 financial results
Aug 24, 2017 13:32 pm UTC| Business
Camposol's LTM EBITDA[1] amounted to USD 96.2MM, net leverage[2] ratio was 1.9x. down from the 2.1x reported last March. During the 2Q-17, Camposol generated an EBITDA of USD 26.1 million, 253%% higher than the EBITDA...
Celsion Announces Presentation of OVATION Study Findings at the Upcoming AACR Special Conference
Aug 24, 2017 13:30 pm UTC| Business
LAWRENCEVILLE, N.J., Aug. 24, 2017 -- Celsion Corporation (NASDAQ:CLSN), an oncology drug development company, today provided an update on its OVATION Study, a Phase Ib dose escalating clinical trial combining GEN-1,...
Aug 24, 2017 13:29 pm UTC| Business
NEW YORK, Aug. 24, 2017 -- Southeast Asia Capital Group, Inc., a Nevada corporation, announced today that the Company has engaged PLS CPAS, a PCAOB-registered independent auditing firm (http://www.plscpas.com), to...
Kimball Electronics, Inc. Announces Stock Repurchase Plan
Aug 24, 2017 13:25 pm UTC| Business
JASPER, Ind., Aug. 24, 2017 -- Kimball Electronics, Inc. (NASDAQ:KE), (the “Company”), today announced that the Board of Directors (the “Board”) of Kimball Electronics, Inc., at its August 23, 2017 meeting, authorized...
Aug 24, 2017 13:23 pm UTC| Business
Company Announcement Phase III ALCYONE study of daratumumab in combination with bortezomib, melphalan and prednisone (VMP) in front line multiple myeloma met the primary endpoint at a pre-planned interim...